---
title: "AIM ImmunoTech Prices $1.3 Million Registered Direct Offering; Adds $5.3 Million Warrant Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289510301.md"
description: "AIM ImmunoTech priced a $1.3 million registered direct offering at $0.5189 per share and issued warrants with potential upside of $5.3 million to institutional investors. Ladenburg Thalmann served as placement agent, receiving fees and warrants. The financing aims to strengthen company liquidity."
datetime: "2026-06-11T20:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289510301.md)
  - [en](https://longbridge.com/en/news/289510301.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289510301.md)
---

# AIM ImmunoTech Prices $1.3 Million Registered Direct Offering; Adds $5.3 Million Warrant Upside

AIM ImmunoTech executed financing agreements to strengthen liquidity, including a Securities Purchase Agreement with institutional investors and a Placement Agency Agreement with Ladenburg Thalmann. The company priced a registered direct offering for approximately $1.3 million at $0.5189 per share and, in a concurrent private placement, issued additional shares plus pre-funded and Class J warrants that could generate about $5.3 million upon cash exercise. Pre-funded warrants are immediately exercisable at $0.001; Class J warrants become exercisable upon stockholder approval at $0.5189 and expire five years after such approval. Ladenburg Thalmann will receive cash fees, expense reimbursement, and placement agent warrants for 306,494 shares at $0.6486.

**Agreement 1: AIM ImmunoTech Prices $1.3 Million Registered Direct Offering With $5.3 Million Warrant Upside**

-   **Agreement type**: Securities Purchase Agreement for registered direct offering and concurrent private placement
-   **Counterparty**: Institutional investors
-   **Signed / Effective**: Jun 09 2026 / same
-   **Duration / Termination**: At will
-   **Reason**: Raise capital and enhance liquidity

**Agreement 2: AIM ImmunoTech Appoints Ladenburg Thalmann as Placement Agent, Issues Warrants and Pays Fees**

-   **Agreement type**: Placement agency agreement for the offerings
-   **Counterparty**: Ladenburg Thalmann
-   **Signed / Effective**: Jun 09 2026 / same
-   **Duration / Termination**: At will
-   **Reason**: Facilitate capital raise execution

Original SEC Filing: AIM ImmunoTech Inc. \[ AIM \] - 8-K - Jun. 11, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [AIM.US](https://longbridge.com/en/quote/AIM.US.md)
- [AIMID.US](https://longbridge.com/en/quote/AIMID.US.md)
- [AIMI.US](https://longbridge.com/en/quote/AIMI.US.md)

## Related News & Research

- [Aim Immunotech’s Aggressive Equity Issuance Raises $10.4M but Poses Major Dilution Risk for Shareholders](https://longbridge.com/en/news/295371378.md)
- [AIM ImmunoTech signs manufacturing pact with Sterling Pharma, cost seen at $1.5 million](https://longbridge.com/en/news/295152135.md)
- [bioAffinity Technologies closes $4 million private placement of pre-funded warrants priced at $0.47](https://longbridge.com/en/news/295951796.md)
- [Gaxos.ai closes warrant exercise at reduced $1.2 per share](https://longbridge.com/en/news/296140843.md)
- [ReconAfrica receives $4.97 million from warrant exercises](https://longbridge.com/en/news/296156008.md)